X0508 4 2025-02-11 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0001991078 Ondrey Aaron C/O ROCKET PHARMACEUTICALS, INC. 9 CEDARBROOK DRIVE CRANBURY NJ 08512 true Chief Financial Officer false Common Stock 2025-02-11 4 A 0 90358 0 A 137139 D Stock Option (Right to Buy) 9.88 2025-02-11 4 A 0 134642 0 A 2035-02-11 Common Stock 134642 134642 D Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years. This option represents a right to purchase a total of 134,642 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. /s/ Martin Wilson, as attorney-in-fact for Aaron Ondrey 2025-02-13